Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
2.900
0.00 (0.00%)
At close: Dec 10, 2025, 4:00 PM EST
2.810
-0.090 (-3.10%)
After-hours: Dec 10, 2025, 7:58 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.98 million as of December 10, 2025. Its market cap has increased by 26.84% in one year.
Market Cap
2.98M
Enterprise Value
-1.69M
1-Year Change
26.84%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.98M, a decrease of -94.82%. That is a compound annual growth rate of -49.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 2.98M | 8.05% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 889.69B |
| Johnson & Johnson | 497.62B |
| AbbVie | 397.98B |
| UnitedHealth Group | 297.45B |
| AstraZeneca | 279.37B |
| Novartis AG | 251.91B |
| Merck & Co. | 242.30B |
| Thermo Fisher Scientific | 215.59B |